Biomarker for diagnosing heart disease and the use thereof
CA 2604575 C · Owner: Matsumori, Akira · Inventors: Matsumori, Akira
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the following methods 1 to 3 and to a kit for carrying out the methods: 1 a method for detecting heart disease characterized in , that the method comprises determining a free immunoglobulin kappa light chain level and/or a free immunoglobulin lambda light chain level of a specimen and comparing at least one value of the kappa chain level, the lambda chain level and a , kappa/lambda ratio with that of a healthy subject; 2 a method for detecting a complication of viral infection in a patient with heart disease, characterized in that the method comprises determining a free immunoglobulin kappa light chain level and/or a free immunoglobulin lambda light chain …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 11, 2006 and granted August 21, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 11, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.